H.W. Frijlink
H.W. Frijlink
Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, The Netherlands
Verified email at rug.nl
TitleCited byYear
Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus
H Heijerman, E Westerman, S Conway, D Touw, ...
Journal of Cystic Fibrosis 8 (5), 295-315, 2009
2442009
Dry powder inhalers for pulmonary drug delivery
HW Frijlink, AH De Boer
Expert opinion on drug delivery 1 (1), 67-86, 2004
2402004
Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water …
DJ Van Drooge, WLJ Hinrichs, MR Visser, HW Frijlink
International journal of pharmaceutics 310 (1-2), 220-229, 2006
1962006
Development of stable influenza vaccine powder formulations: challenges and possibilities
JP Amorij, A Huckriede, J Wilschut, HW Frijlink, WLJ Hinrichs
Pharmaceutical research 25 (6), 1256-1273, 2008
1822008
Technological and practical challenges of dry powder inhalers and formulations
M Hoppentocht, P Hagedoorn, HW Frijlink, AH De Boer
Advanced drug delivery reviews 75, 18-31, 2014
1802014
Application of process analytical technology in tablet process development using NIR spectroscopy: Blend uniformity, content uniformity and coating thickness measurements
JJ Moes, MM Ruijken, E Gout, HW Frijlink, MI Ugwoke
International journal of pharmaceutics 357 (1-2), 108-118, 2008
1752008
Which shape factor (s) best describe granules?
AM Bouwman, JC Bosma, P Vonk, JHA Wesselingh, HW Frijlink
Powder Technology 146 (1-2), 66-72, 2004
1672004
Inulin, a flexible oligosaccharide I: Review of its physicochemical characteristics
MA Mensink, HW Frijlink, K van der Voort Maarschalk, WLJ Hinrichs
Carbohydrate polymers 130, 405-419, 2015
1652015
Inulin glasses for the stabilization of therapeutic proteins
WLJ Hinrichs, MG Prinsen, HW Frijlink
International journal of pharmaceutics 215 (1-2), 163-174, 2001
1652001
A novel bottom–up process to produce drug nanocrystals: controlled crystallization during freeze-drying
H De Waard, WLJ Hinrichs, HW Frijlink
Journal of Controlled Release 128 (2), 179-183, 2008
1612008
A review of the technical aspects of drug nebulization
PPH Le Brun, AH De Boer, HW Frijlink, HGM Heijerman
Pharmacy World & Science 22 (3), 75-81, 2000
1612000
The effect of parenterally administered cyclodextrins on cholesterol levels in the rat
HW Frijlink, AC Eissens, NR Hefting, K Poelstra, CF Lerk, DKF Meijer
Pharmaceutical research 8 (1), 9-16, 1991
1611991
Breaking of scored tablets: a review
E Van Santen, DM Barends, HW Frijlink
European Journal of Pharmaceutics and Biopharmaceutics 53 (2), 139-145, 2002
1502002
Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses …
JP Amorij, V Saluja, AH Petersen, WLJ Hinrichs, A Huckriede, HW Frijlink
Vaccine 25 (52), 8707-8717, 2007
1472007
A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation
V Saluja, JP Amorij, JC Kapteyn, AH de Boer, HW Frijlink, WLJ Hinrichs
Journal of Controlled Release 144 (2), 127-133, 2010
1392010
Powder formulation disintegrating system and method for dry powder inhalers
AH de Boer, HW Frijlink, D Gjaltema, J Goede, P Hagedoorn
US Patent 6,681,768, 2004
1392004
Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique
AH De Boer, D Gjaltema, P Hagedoorn, HW Frijlink
International journal of pharmaceutics 249 (1-2), 219-231, 2002
1392002
Air classifier technology (ACT) in dry powder inhalation: Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier …
AH De Boer, P Hagedoorn, D Gjaltema, J Goede, HW Frijlink
International journal of pharmaceutics 260 (2), 187-200, 2003
1262003
Needle-free influenza vaccination
JP Amorij, WLJ Hinrichs, HW Frijlink, JC Wilschut, A Huckriede
The Lancet infectious diseases 10 (10), 699-711, 2010
1142010
Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2: inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and …
PPH Le Brun, AH De Boer, GPM Mannes, DMI De Fraıˆture, ...
European Journal of Pharmaceutics and Biopharmaceutics 54 (1), 25-32, 2002
1102002
The system can't perform the operation now. Try again later.
Articles 1–20